OVERVIEW

Advancements in Cancer Management is organized by Cancer Treatment Centers of America® (CTCA).

Released: June 28, 2019
Expires: June 28, 2020

Intended Audience:
Advancements in Cancer Management is designed to meet the educational needs of primary care providers and specialists involved in the care of patients with cancer.

Maximum Credits:
3.25 / AMA PRA Category 1 Credit™.

Description:
Advancements in Cancer Management highlights 5 presentations from a 2019 spring live lecture series. Videos are packaged into short chapters, featuring topics such as screening high-risk patients, cancer pain management, immunotherapy treatment and adverse event management, monitoring for the long-term effects of treatment and/or disease, combining integrative therapies with cancer treatment, and drug-drug interactions.

Educational Objectives:
Upon completion of this activity, participants will be able to:
• Explain the use of multimodal analgesia to manage pain and reduce the use of opioids.
• Describe how integrative therapies and lifestyle change programs are employed as adjunct therapies in the care of patients with cancer.
• Evaluate immuno-oncology approaches in cancer treatment, including patient selection.
• Describe the appropriate follow-up protocols for identification of pulmonary nodules.
• Recognize the pathophysiology and clinical presentations of various subtypes of pleural effusions.
• Describe the various treatment options for each of the various pleural effusions.

Additional details will be posted as soon as they are available.

Credits
  • 3.25 CME
  • SPECIALITIES

    Oncology

    RELATED ONLINE COURSES

    May 25, 2022 - Nov 30, 2026 | Webcast

    State required course for Connecticut ...
    5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$180

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$15.20

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$102